Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical Countermeasures Medical Countermeasures March 18, 2025 …
A Clear Picture of Poxvirus Cores Could Help Build Better Countermeasures Research February 5, 2024 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve Medical Countermeasures September 13, 2023 …
Treatments for Poxviruses May Already Exist in Licensed Drugs Medical Countermeasures August 9, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control Medical Countermeasures June 21, 2022 …
Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs Industry News June 20, 2022 …
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine Medical Countermeasures May 30, 2022 …
A Family Drama: The Sexual Politics of Smallpox Vaccination in the Spanish Empire February 26, 2021 …
BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic Industry News February 19, 2021 …
Lessons for COVID-19 Pandemic from the Massive Public Health Effort to Eradicate Smallpox Historical Reflections June 27, 2020 …
Phase 3 Trial of Modified Vaccinia Ankara as a Smallpox Vaccine Medical Countermeasures November 14, 2019 …
